May 19, 2022 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are nineteen patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first …
May 19, 2022 Comments Off on New patent for Ironwood Pharms drug DUZALLO Posted in: Patent Added Annual Drug Patent Expirations for DUZALLO Duzallo is a drug marketed by Ironwood Pharms Inc and is included in one NDA. There are nine patents protecting this drug. DUZALLO drug…
The post New patent for Ironwood Pharms drug DUZALLO appeared first on D…
